Purpose To evaluate the inter-device agreement among the Goldmann applanation tonometer (GAT), iCare and Icare PRO rebound tonometers, non-contact tonometer (NCT), and Tonopen XL tonometer. Methods Sixty healthy elderly subjects were enrolled. The intraocular pressure (IOP) in each subject's right eye was measured thrice using each of the five tonometers. Intra-device agreement was evaluated by calculating intraclass correlation coefficients (ICCs). Inter-device agreement was evaluated by ICC and Bland-Altman analyses. Results ICCs for intra-device agreement for each tonometer were [0.8. IOP as measured by iCare (mean ± SD, 11.6 ± 2.5 mmHg) was significantly lower (p \ 0.05) than that measured by GAT (14.0 ± 2.8 mmHg), NCT (13.6 ± 2.5 mmHg), Tonopen XL (13.7 ± 4.1 mmHg), and Icare PRO (12.6 ± 2.2 mmHg; Bonferroni test). There was no significant difference in mean IOP among GAT, NCT, and Tonopen XL. Regarding inter-device agreement, ICC was lower between Tonopen XL and other tonometers (all ICCs \ 0.4). However, ICCs of GAT, iCare, Icare PRO, and NCT showed good agreement (0.576-0.700). The Bland-Altman analysis revealed that the width of the 95% limits of agreement was larger between the Tonopen XL and the other tonometers ranged from 14.94 to 16.47 mmHg. Among the other tonometers, however, the widths of 95% limits of agreement ranged from 7.91 to 9.24 mmHg. Conclusion There was good inter-device agreement among GAT, rebound tonometers, and NCT. Tonopen XL shows the worst agreement with the other tonometers; therefore, we should pay attention to its' respective IOP. Clinical trial registration Japan Clinical Trials Register; number: UMIN000011544.
Introduction
Measurement of intraocular pressure (IOP) is one of the most important ophthalmic examinations in addition to visual acuity testing and vitreoretinal examination using fundoscopy. The Goldmann applanation tonometer (GAT) was developed in 1955 [1] and is still recognized as the gold standard tonometer, particularly for monitoring patients with glaucoma. The Mackay-Marg tonometer (Tonopen) was developed in 1959, soon after GAT [2] , as a portable tonometer. Additionally, air-puff tonometry, which is performed using a non-contact tonometer (NCT), was developed [30 years ago [2] . A new tonometric mechanism, which is used in the iCare Ò rebound tonometer, has been available for clinical practice since 1996 [3] ; it can be used without topical anesthesia and is particularly useful for measuring IOP in children [4] .
The updated version of the rebound tonometer, the Icare PRO Ò , has updated features, including a built-in inclination sensor that permits IOP to be measured with the patient in the supine position, because the new probe does not fall out when the tonometer is not upright [5] .
In clinical practice, various tonometers can be used, and we have to switch the tonometer depending on the situation (e.g., in children, bed-ridden patients, and poorly compliant patients). Agreement and repeatability among some devices have been reported previously [5] [6] [7] [8] [9] [10] [11] [12] . However, to the best of our knowledge, the agreement among GAT, rebound tonometers, NCT, and Tonopen XL has not been investigated. Therefore, in the present study, we evaluated the agreement and repeatability among them in healthy elderly subjects.
Subjects and methods
This prospective study was approved by the institutional review board of Saneikai Tsukazaki Hospital and was performed according to the tenets of the Declaration of Helsinki. Healthy elderly subjects were recruited from the hospital between April 2014 and May 2016. Written informed consent was obtained from each subject before participation in this study. All subjects underwent an ophthalmic examination, including fundoscopy, without pupil dilation before measurements were taken from the right eye. Subjects who had not previously undergone ocular surgery and did not have any ocular disease except for senile cataracts were included in the study.
These elderly subjects were enrolled as control subjects in the ''Comparison of intraocular pressure measurements after penetrating keratoplasty (PKP) and Descemet's stripping automated endothelial keratoplasty (DSAEK)'' study, which is registered with the Japan Clinical Trials Register; number: UMIN000011544.
Corneal curvature (CC) was measured using an autorefractor (KR-8800; Topcon Corporation, Japan), and the mean of five measurements was used for subsequent analyses. The CC was defined as the average of the horizontal (K1) and vertical (K2) CCs. Central corneal thickness (CCT) was measured by three-dimensional corneal and anterior segment optical coherence tomography (SS-1000; CASIA, Tomey, JAPAN), and the mean of three measurements was used for subsequent analyses. The axial length (AL) of the eye was measured using an IOLMaster, ver 5.02 (Carl Zeiss Meditec, Jena, Germany), and the mean of five measurements was used in subsequent analyses. The CC, CCT, and AL were measured by one of three expert operators (N.M., K.Y., and M.H.). For each subject, all IOP measurements were taken on the same day, using the tonometers in the same order, as follows: NCT, iCare, Icare PRO, Tonopen XL, and then GAT. To measure IOP precisely, iCare, Icare PRO, and Tonopen XL were measured with the subjects chin placed on the slit-lamp chin rest.
For a given subject, three sets of IOP measurements were obtained using each tonometer. The operators were randomized, except for those assigned to GAT. NCT, iCare, Icare PRO, and Tonopen XL measurements were taken by one of three expert operators (N.M., K.Y., and M.H.); GAT measurements were taken by an experienced ophthalmologist (either S.N. or Y.K), because the use of GAT is generally restricted to ophthalmologists in Japan. For measuring GAT, the operator was masked to the readings of the previous four tonometers, and the reading of GAT was taken by the same operator. All IOP measurements were taken without using an eyelid speculum, and a 1-min interval separated for each device.
These three sets of IOP readings were used for both intra-and inter-device data comparisons. We selected the order of measurements on the basis of the degree of invasion required on the corneal surface (i.e., the less invasive devices were used first) and on whether topical anesthesia was needed for the procedure (i.e., devices requiring topical anesthesia were used last).
NCT: air-puff tonometry CT-90A (Topcon, Tokyo, Japan) is a standard noncontact tonometer that was used to measure three sets of IOPs. The mechanism of measuring IOP in noncontact tonometry involves detecting flattening of the cornea after air-puff via the reflection of an installed infrared light.
iCare: rebound tonometer
The iCare tonometer (Tiolat Oy, Helsinki, Finland) is a rebound tonometer that bounces a probe off the cornea and subsequently measures the deceleration of the probe. IOP measurements were taken 4-8 mm from the center of the cornea, according to the manufacturer's instructions. For this device, after six consecutive measurements, the result is given with a letter P on the display, followed by the IOP. The symbols P-and P_ indicate that the standard deviation of the different measurements is greater than normal. If these appeared, we took a new measurement to ensure precision. The mean of three consecutive sets of acceptable measurements was used for subsequent analyses [5] .
Icare PRO: rebound tonometer
The Icare PRO tonometer (Tiolat Oy, Helsinki, Finland) is an updated version of the iCare rebound tonometer and has been available since 2011. The device functions by bouncing a novel magnetized probe, which is different from the iCare probe, off the cornea and measuring the subsequent deceleration of the probe. IOP measurements were taken with the tonometer positioned 3-7 mm from the center of the cornea, according to the manufacturer's instructions. After six consecutive measurements, a background color is displayed, followed by the IOP. Yellow or red indicates a slightly high or high standard deviation among the different measurements, respectively. If yellow or red appeared, we repeated the procedure until an IOP was obtained that displayed with a green background, which indicates an accurate final measurement. The mean of three consecutive sets of acceptable final measurements was used for subsequent analyses [5] . The Icare PRO also uses a magnetized probe so that measurements can be made with the patient in a supine position.
Tonopen XL: combined applanation and indentation tonometer
The Tonopen XL (Menter, Norwell, MA, USA) measures IOP over a small area of the cornea with a 1.0-mm transducer tip using the principles of the Mackay-Marg tonometer, which combines the mechanisms of both indentation and applanation tonometers. Before taking the measurement, a topical anesthetic-oxybuprocaine hydrochloride 0.4% (Benoxyl)-was applied to the right eye. After four consecutive measurements were taken, the final mean value was provided digitally, with the error margin; the mean of three consecutive sets of acceptable measurements (i.e., final values with an error margin of\5%) was used for subsequent analyses [13] .
GAT: applanation tonometer GAT indirectly measures IOP by measuring the spring force necessary to applanate a certain area of the cornea; a principle based on the Imbert-Fick law [2] . Each subject's chin was placed on the slit-lamp chin rest for this measurement. The subjects were given oxybuprocaine hydrochloride 0.4% (Benoxyl) with fluorescein as a topical anesthetic. The mean of three consecutive measurements was used for subsequent analyses.
Statistical analysis
Statistical analyses were performed using JMP, version 10.0.0 (SAS Institute Inc., Cary, NC, USA) and Statcel 3 (OMS Publishing Ltd, Tokyo, JAPAN). Data were expressed as the mean ± standard deviation (SD). The repeatability (intra-device agreement) of the three consecutive measurements for each tonometer was evaluated by calculating intraclass correlation coefficients [ICC (1, 1)] (i.e., intra-rater reliability, one-way random effects model). The mean of three IOP reading sets was used to determine the intradevice agreement.
Inter-device differences were evaluated using the repeated measure analysis of variance and the Bonferroni multiple comparison tests to detect any significant divergences among the five devices. Inter-device agreement was evaluated by ICC (3, 1) (i.e., inter-rater reliability, two-way mixed effects model). An ICC value of 0 indicates the level of agreement produced by chance alone, and a value of 1 indicates perfect positive agreement. For the purposes of our study, we defined very good agreement as ICC values [0.7, good agreement as ICC values of 0.4-0.7, and poor agreement as ICC values \0.4, according to the principles of McGraw and Wong [14] .
In the Bland-Altman analysis, the distribution of measurements was expressed as the mean difference between two devices with SD, and additionally in terms of the 95% limits of agreement (LOA), which were defined as the mean ± 1.96 SD. Pearson's correlation coefficient was also used to evaluate optical biometric measurements (i.e., CCT, AL, and CC) against IOP readings obtained by five tonometers to elucidate any relationships therein. A p value\0.05 was considered to indicate statistical significance.
Results

Subjects demographics
Measurements from the right eye of 60 subjects (38 females, 22 males) were included in this study. The mean age of the subjects was 71.0 ± 7.5 years (range 53-90 years). The mean CCT was 532.7 ± 31.0 lm (range 469-628.7 lm). The mean AL was 23.6 ± 1.13 mm (range 20.92-26.74 mm). The mean CC was 7.58 ± 0.23 mm (range 6.88-8.28 mm). Table 1 shows the results of IOP measurements taken from the subjects using the five different tonometers. The mean IOP was highest for GAT (14.0 ± 2.8 mmHg) and lowest for the iCare (11.6 ± 2.5 mmHg). Intradevice repeatability was evaluated in terms of ICC (1,1). The intra-device agreement for each tonometer was very good (all ICCs were [0.8 and ranged from 0.881 to 0.975).
IOP
Repeated measure analysis of variance (ANOVA) showed a statistically significant difference for the tonometers (F value = 13.65, p \ 0.001). Figure 1 shows the box plots of the mean IOP readings from each of the five tonometers. Multiple comparison tests (Bonferroni test) showed a statistically significant difference in the mean IOP readings between the iCare (11.6 ± 2.5 mmHg) and GAT (14.0 ± 2.8 mmHg), between iCare and Icare PRO (12.6 ± 2.2 mmHg), between the iCare and NCT (13.6 ± 2.5 mmHg) and between the iCare and the Tonopen XL (13.7 ± 4.1 mmHg) (p \ 0.05 for all). Additionally, multiple comparison tests showed a statistically significant difference between Icare PRO and GAT and between Icare PRO and NCT (p \ 0.05 for all).
No significant differences in the mean IOPs were found among GAT, NCT, and Tonopen XL and between Icare PRO and Tonopen XL (p [ 0.05). ICC intraclass correlation coefficients (1, 1) (i.e., intra-rater reliability, one-way random effects model) The post hoc power analysis of repeated measures ANOVA for evaluating the inter-device differences using effect size f = 0.48, number of measures = 5 and sample size = 60 from results of this study showed 0.999 of statistical power set as a = 0.05.
The effect size f was calculated as (variance explained by effect = 252.507/variance within group = 1091.439)^0.5 which was obtained from repeated measures ANOVA. Table 2 shows the inter-device agreement, as evaluated by ICC (3,1) testing. There was good agreement among ICCs for GAT, the iCare, the Icare PRO, and NCT (all ICCs [ 0.5; range 0.576-0.700) ( Table 2 ). However, there was poor agreement between the Tonopen XL and the other tonometers (all ICCs \ 0.4; range 0.201-0.384).
Inter-device agreement, as assessed by BlandAltman analysis Differences in the means of the IOP measurements were subjected to Bland-Altman analysis, and the results are presented in Table 3 . The mean differences among the Tonopen XL and the other tonometers were small and ranged from -2.19 to 0.27 mmHg; however, the SD values of the mean difference (range 3.81-4.20 mmHg) were larger than the other SD values (of about 2 mmHg) for other pairs.
The Bland-Altman analysis of comparisons among GAT and other tonometers is shown in Fig. 2 . Figure 2a shows a comparison of GAT and iCare performance.
The mean difference was 2.46 ± 2.10 mmHg, which showed that there was no correlation of measurements with the IOP level (r = 0.14, p = 0.285). There was good agreement between GAT and the iCare within normal IOP values. Figure 2b shows the comparison between performance of GAT and the Icare PRO. The mean difference was 1.42 ± 2.35 mmHg, and there was a weak correlation of measurements with the IOP level (r = 0.26, p = 0.042). There was good agreement between GAT and the Icare PRO within normal IOP values. Figure 2c shows a comparison of GAT and NCT performance.
The mean difference was 0.37 ± 2.17 mmHg, which showed that there was no correlation of measurements with the IOP level (r = 0.12, p = 0.329). There was good agreement between GAT and NCT within normal IOP values. Figure 3 shows the results of Bland-Altman analysis between the iCare and the Icare PRO. The mean difference between the iCare and the Icare PRO was -1.0 ± 2.0 mmHg, which showed that there was no correlation of measurements with the IOP level (r = 0.15, p = 0.249). There was good agreement between the iCare and the Icare PRO within normal IOP values.
Effects of CCT, AL, and CC on IOP measurements using five tonometers
The bivariate relationships among IOPs and CCT, AL, and CC for the five tonometers are presented in Table 4 . The IOP measurements demonstrated a weak correlation with CCT for GAT, the Icare PRO, and NCT (r = 0.28, 0.26, and 0.43, respectively).
Discussion
Intra-and inter-device agreement among the tonometers
Our results show that there was very good intra-device agreement among three sets of IOP readings taken in the sitting position, as evaluated by ICC (ICCs [ 0.8). Our previous studies [5, 13] also showed that ICCs were very good ([0.8) and independent of body position for the Kowa handheld applanation tonometer (GAT-type tonometer) [5, 13] , iCare [13] , and Tonopen XL [5, 13] . Icare PRO performance was very good for subjects in the sitting position (ICCs = 0.881 [this study] and 0.863 [5] ); however, it performed slightly worse for subjects in the supine position (ICC = 0.656) [5] .
Tonopen XL exhibited poor inter-device agreement. No significant difference was found in mean IOP among GAT, NCT, and Tonopen XL (p [ 0.05). The mean IOP as measured by Tonopen XL (13.7 ± 4.1 mmHg) was not statistically different from those of GAT (14.0 ± 2.8 mmHg), NCT (13.6 ± 2.5 mmHg), and Icare PRO (12.6 ± 2.2 mmHg). However, ICCs between Tonopen XL and other the tonometers were all\0.4. Additionally, Bland-Altman plots showed that the LOAs had wider 95% limits (range 14.94-16.34 mmHg) when the Tonopen XL was compared with the other tonometers than for comparisons among the other tonometers (range 7.91-9.24 mmHg). GAT is still the gold standard tonometer, and agreements between other tonometers and GAT are important in clinical practice. The means of the differences and the 95% limits of the LOAs between GAT and NCT, iCare, and Tonopen XL were 0.37 and 8.51 mmHg, 2.46 and 8.25 mmHg, and 0.27 and 16.34 mmHg, respectively. One systematic review [15] reported that the means of the differences and the widths of the 95% LOAs between GAT and NCT, iCare, and Tonopen were 0.2 and 8.1 mmHg, 0.9 and 10.4 mmHg, and -0.2 and 12 mmHg, respectively. Our data had slightly wider variability than these previously reported results. The results from the systematic review also suggested that NCT had the lowest variability, compared with GAT [15] . We also found that NCT had the lowest variability in the mean of the differences and a narrower width of the 95% LOA than GAT. The second lowest variability in the difference compared to GAT was observed for Icare PRO tonometer, and the third was for iCare; Tonopen XL tonometer showed the highest variability ( Fig. 2a-d ).
In our study, the mean IOP as measured by iCare was statistically lower than those measured by the other tonometers, as indicated by multiple comparisons testing (p \ 0.05, Bonferroni test). However, previous reports have shown that iCare tonometer gave slightly higher readings than GAT [7, 16] ; this could be because iCare probe has a tendency to be more affected by patients' ages than other tonometers [17] . Our subjects were older, with a mean age of 72 years versus approximately 50 years for patients in previous reports [7, 16] .
iCare versus Icare PRO rebound tonometers Icare PRO is a position-independent rebound tonometer that uses a different type of probe than the iCare, Icare ONE [17, 18] self-/home tonometer, and Icare HOME tonometer, which is an updated version of Icare ONE tonometer [19] . Agreement among the Icare PRO, NCT, and GAT has been reported to be good [12] , and Icare PRO indicates slightly lower IOPs than GAT [12] , which is consistent with our results.
Only one previous study has investigated the agreement between the two different types of probes used in Icare ONE and Icare PRO [18] . In that study, the mean IOPs were 17.5 ± 5.4 mmHg for Icare ONE and 16.6 ± 4.7 mmHg for Icare PRO (p = 0.31), and the Bland-Altman analysis showed that Icare ONE had a tendency to overestimate IOPs in patients who had IOPs higher than approximately 16 mmHg [18] .
In our study, the mean of the difference was only 1 mmHg, and the width of the 95% LOA was very small, at 8.09 mmHg. There was good agreement between the two devices (Fig. 3) .
Relationships between tonometers and ocular biometry
In our study, statistically positive correlations were found between the IOP measurements obtained with GAT, NCT, and Icare PRO and CCT (r = 0.28, 0.43, 0.26, p \ 0.05, respectively). Almost all tonometers are affected by CCT in the sitting position [20] . Based on our results, NCT was most affected by CCT (r = 0.43), which correlates well with a previous report [12] . This previous study reported that the correlation coefficients (r) between GAT, NCT, and Icare PRO and the CCT were 0.168, 0.327, and 0.212, respectively. Therefore, extra attention should be given to patients with thicker or thinner CCTs, particularly when using NCT. In this study, there was no significant correlation between IOP and CC or AL in all devices.
There is disagreement about the effect of CC on IOP in many reports; however, the effect is generally considered to be minor [20] . The effect of AL on IOP is controversial. Mark et al. reported that subjects with longer AL had lower IOPs [21] . However, Wong et al. presented evidence that myopic refractions correlated with both high IOP and prevalent glaucoma [22] .
A limitation of our study was that our subjects were all healthy subjects; therefore, our results may not be directly applicable to children or glaucoma patients because the corneal biomechanical properties are known to affect IOP measurements [23, 24] . The corneal biomechanical properties are affected by age [25] and are different between healthy subjects and glaucoma subjects [26, 27] . The age-related biomechanical changes may be one reason why the worst agreement was observed among Tonopen XL and other tonometers that did not coincide with our previous reports [5, 13] which studied younger subjects. Each tonometer has its own physical principles for IOP measurement; therefore, the effect of agerelated biomechanical changes on the IOP value must be different in each device. iCare (Icare ONE; portable self-measuring tonometer of iCare) [17] and NCT [28] showed underestimation compared with GAT with higher age, but it was borderline in Tonopen XL (p = 0.05) [28] . However, elderly subjects have a higher prevalence of glaucoma than do younger subjects [29] ; therefore, measurement of IOP is more important in elderly subjects than in younger subjects, and establishing agreement among tonometers used in clinical practice is critical for accurate monitoring of IOPs.
The second is that we took IOP measurements at 1-min intervals with each device and not in a randomized order. This interval may be adequate in clinical practice; however, it may inadequate to compensate for measurement-related temporary changes of the corneal rigidity. However, we measured IOP in accordance to the least invasive method used first. Therefore, one measurement will have the least effect on the next measurement. Additionally, we did not find any report showing the proper interval for IOP measurements based on corneal rigidity.
The third is that we did not evaluate inter-observer repeatability for each device.
In summary, the results of the present study highlight the agreement among the currently available ophthalmic tonometers in healthy elderly subjects. In clinical practice, we should use the same tonometer throughout the follow-up of one patient. However, it is possible to switch the tonometer depending on the situation (e.g., in children, bed-ridden patients, and poorly compliant patients).
Rebound tonometers (iCare, Icare PRO tonometer) give slightly lower mean IOPs compared with GAT and NCT; however, there was good inter-device agreement among them. Therefore, we can use one tonometer as a substitute for the others by giving importance to each IOP difference. However, Tonopen XL shows the worst agreement with the other tonometers. Clinicians should pay attention to the interpretation the values of Tonopen XL in healthy elderly subjects.
